(MZX) Masterflex SE - Ratings and Ratios
High-Tech Hoses, Tubing, Connectors,
MZX EPS (Earnings per Share)
MZX Revenue
Description: MZX Masterflex SE
Masterflex SE is a German-based company that specializes in the development, production, and distribution of high-tech hoses and connecting systems for various industrial applications. The companys product portfolio is diverse, catering to industries such as medical technology, renewable energy, aviation, automotive, and e-mobility. With a strong presence in Europe and a global footprint, Masterflex SE operates through multiple brand names, including Masterflex, Matzen & Timm, Novoplast Schlauchtechnik, Fleima-Plastic, and Masterduct, offering a wide range of products such as spiral hoses, connectors, clamps, and custom-molded parts.
From a market perspective, Masterflex SE is listed on the XETRA exchange under the ticker symbol MZX, and is classified under the Specialty Chemicals sub-industry. The companys market capitalization stands at approximately 95.41 million EUR, with a price-to-earnings ratio of 12.10 and a return on equity of 13.33%. These metrics indicate a relatively stable and profitable company.
Analyzing the technical data, Masterflex SEs stock price has shown a positive trend, with the last price at 11.55 EUR, which is also its 52-week high. The stocks short-term and long-term moving averages (SMA20 and SMA50) are 10.40 and 10.21, respectively, indicating a bullish trend. The average true range (ATR) is 0.40, representing a 3.43% volatility. Based on this data, it is likely that the stock will continue its upward trajectory.
Combining the fundamental and technical data, a forecast for Masterflex SE can be derived. With a stable market capitalization, a reasonable P/E ratio, and a positive return on equity, the companys financials appear solid. The technical indicators also point towards a continued upward trend, driven by the companys strong product portfolio and diversified industry presence. Therefore, it is forecasted that Masterflex SEs stock price will continue to rise, potentially reaching 12.50 EUR in the short term, driven by its strong fundamentals and positive market sentiment.
MZX Stock Overview
| Market Cap in USD | 134m |
| Sector | Basic Materials |
| Industry | Specialty Chemicals |
| GiC Sub-Industry | Specialty Chemicals |
| IPO / Inception |
MZX Stock Ratings
| Growth Rating | 81.9 |
| Fundamental | 72.6% |
| Dividend Rating | 61.7 |
| Rel. Strength | 35.6 |
| Analysts | - |
| Fair Price Momentum | 15.76 EUR |
| Fair Price DCF | 42.12 EUR |
MZX Dividends
| Dividend Yield 12m | 2.31% |
| Yield on Cost 5y | 6.52% |
| Annual Growth 5y | 48.17% |
| Payout Consistency | 63.0% |
| Payout Ratio | 40.4% |
MZX Growth Ratios
| Growth Correlation 3m | 70.3% |
| Growth Correlation 12m | 58.4% |
| Growth Correlation 5y | 87.6% |
| CAGR 5y | 28.20% |
| CAGR/Max DD 5y | 0.73 |
| Sharpe Ratio 12m | -0.08 |
| Alpha | 20.62 |
| Beta | 0.159 |
| Volatility | 84.58% |
| Current Volume | 17.4k |
| Average Volume 20d | 0.9k |
| Stop Loss | 13 (-3.7%) |
As of August 09, 2025, the stock is trading at EUR 13.50 with a total of 17,434 shares traded.
Over the past week, the price has changed by +11.57%, over one month by -0.74%, over three months by +22.48% and over the past year by +37.79%.
Partly, yes. Based on ValueRay´s Fundamental Analyses, Masterflex SE (XETRA:MZX) is currently (August 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 72.57 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MZX is around 15.76 EUR . This means that MZX is currently undervalued and has a potential upside of +16.74% (Margin of Safety).
Masterflex SE has no consensus analysts rating.
According to our own proprietary Forecast Model, MZX Masterflex SE will be worth about 17 in August 2026. The stock is currently trading at 13.50. This means that the stock has a potential upside of +26.07%.
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 15.9 | 17.8% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 17 | 26.1% |
Piotroski VR‑10 (Strict) 6.0
| Net Income (8.43m TTM) > 0 and > 6% of Revenue (6% = 5.96m TTM) |
| FCFTA 0.11 (>2.0%) and ΔFCFTA 0.87pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 38.23% (prev 17.45%; Δ 20.77pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.13 (>3.0%) and CFO 13.0m > Net Income 8.43m (YES >=105%, WARN >=100%) |
| Net Debt (-10.3m) to EBITDA (18.2m) ratio: -0.57 <= 3.0 (WARN <= 3.5) |
| Current Ratio 4.55 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (9.50m) change vs 12m ago 0.39% (target <= -2.0% for YES) |
| Gross Margin 61.23% (prev 58.84%; Δ 2.39pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 102.9% (prev 104.3%; Δ -1.45pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 9.90 (EBITDA TTM 18.2m / Interest Expense TTM 1.28m) >= 6 (WARN >= 3) |
Altman Z'' 5.50
| (A) 0.39 = (Total Current Assets 48.7m - Total Current Liabilities 10.7m) / Total Assets 97.7m |
| (B) 0.27 = Retained Earnings (Balance) 26.1m / Total Assets 97.7m |
| (C) 0.13 = EBIT TTM 12.6m / Avg Total Assets 96.6m |
| (D) 1.14 = Book Value of Equity 35.7m / Total Liabilities 31.4m |
| Total Rating: 5.50 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay Score 72.57
| 1. Piotroski 6.0pt = 1.0 |
| 2. FCF Yield 8.59% = 4.30 |
| 3. FCF Margin 10.77% = 1.79 |
| 4. Debt/Equity 0.30 = 2.46 |
| 5. Debt/Ebitda 1.10 = 1.63 |
| 6. ROIC - WACC 8.21% = 8.21 |
| 7. RoE 13.34% = 2.22 |
| 8. Rev. Trend -20.87% = -5.0 |
| 9. Rev. CAGR 3.00% = 0.37 |
| 10. EPS Trend 9.37% = 5.0 |
| 11. EPS CAGR 5.83% = 0.58 |
MZX Fundamental Data Overview
Market Cap EUR = 114.9m (114.9m EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 10.3m EUR (Cash And Short Term Investments, last quarter)
P/E Trailing = 13.5795
P/S = 1.1553
P/B = 1.6405
Beta = 0.735
Revenue TTM = 99.4m EUR
EBIT TTM = 12.6m EUR
EBITDA TTM = 18.2m EUR
Long Term Debt = 18.4m EUR (from longTermDebt, last quarter)
Short Term Debt = 1.56m EUR (from shortTermDebt, last quarter)
Debt = 20.0m EUR (Calculated: Short Term 1.56m + Long Term 18.4m)
Net Debt = -10.3m EUR (from netDebt column, last quarter)
Enterprise Value = 124.6m EUR (114.9m + Debt 20.0m - CCE 10.3m)
Interest Coverage Ratio = 9.90 (Ebit TTM 12.6m / Interest Expense TTM 1.28m)
FCF Yield = 8.59% (FCF TTM 10.7m / Enterprise Value 124.6m)
FCF Margin = 10.77% (FCF TTM 10.7m / Revenue TTM 99.4m)
Net Margin = 8.48% (Net Income TTM 8.43m / Revenue TTM 99.4m)
Gross Margin = 61.23% ((Revenue TTM 99.4m - Cost of Revenue TTM 38.5m) / Revenue TTM)
Tobins Q-Ratio = 3.49 (Enterprise Value 124.6m / Book Value Of Equity 35.7m)
Interest Expense / Debt = 1.32% (Interest Expense 264.0k / Debt 20.0m)
Taxrate = 26.12% (from yearly Income Tax Expense: 2.93m / 11.2m)
NOPAT = 9.34m (EBIT 12.6m * (1 - 26.12%))
Current Ratio = 4.55 (Total Current Assets 48.7m / Total Current Liabilities 10.7m)
Debt / Equity = 0.30 (Debt 20.0m / last Quarter total Stockholder Equity 66.0m)
Debt / EBITDA = 1.10 (Net Debt -10.3m / EBITDA 18.2m)
Debt / FCF = 1.87 (Debt 20.0m / FCF TTM 10.7m)
Total Stockholder Equity = 63.2m (last 4 quarters mean)
RoA = 8.63% (Net Income 8.43m, Total Assets 97.7m )
RoE = 13.34% (Net Income TTM 8.43m / Total Stockholder Equity 63.2m)
RoCE = 15.50% (Ebit 12.6m / (Equity 63.2m + L.T.Debt 18.4m))
RoIC = 13.98% (NOPAT 9.34m / Invested Capital 66.8m)
WACC = 5.77% (E(114.9m)/V(134.9m) * Re(6.60%)) + (D(20.0m)/V(134.9m) * Rd(1.32%) * (1-Tc(0.26)))
Shares Correlation 5-Years: -70.70 | Cagr: -0.25%
Discount Rate = 6.60% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 81.58% ; FCFE base≈10.3m ; Y1≈13.1m ; Y5≈24.4m
Fair Price DCF = 42.12 (DCF Value 405.2m / Shares Outstanding 9.62m; 5y FCF grow 30.0% → 2.90% )
Revenue Correlation: -20.87 | Revenue CAGR: 3.00%
Revenue Growth Correlation: 35.01%
EPS Correlation: 9.37 | EPS CAGR: 5.83%
EPS Growth Correlation: 29.02%